Update shared on06 Aug 2025
Fair value Increased 8.44%The analyst price target for Narayana Hrudayalaya has increased to ₹1790, driven by higher consensus revenue growth forecasts and a lower expected future P/E multiple.
What's in the News
- Board meeting scheduled to approve unaudited Q1 FY26 results and consider revised proposal to raise capital via debt securities on a private placement basis, subject to shareholder approval in the upcoming AGM.
- Expected release of Q1 FY26 results on August 1.
- Annual dividend of INR 4.50 per share announced, payable September 28, with ex-date and record date on August 1.
- Board meeting previously held to approve audited annual results, recommend dividend, and discuss debt issuance proposal, also subject to shareholder approval at the AGM.
Valuation Changes
Summary of Valuation Changes for Narayana Hrudayalaya
- The Consensus Analyst Price Target has risen from ₹1689 to ₹1790.
- The Consensus Revenue Growth forecasts for Narayana Hrudayalaya has significantly risen from 11.4% per annum to 12.8% per annum.
- The Future P/E for Narayana Hrudayalaya has fallen from 41.54x to 38.45x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.